2018 AVBCC Summit Agenda

October 30-31, 2018 | New York Athletic Club, New York, NY

Tuesday, October 30

6:30 am – 7:30 am	Mini-Roundtables
6:30 am – 7:30 am	Networking Breakfast \| Exhibit Hall
7:30 am	Opening Remarks and Greeting Burt Zweigenhaft, Co-Chair, AVBCC
7:30 am – 8:30 am	Keynote: FDA Perspectives Scott Gottlieb, MD, FDA Commissioner
8:30 am – 9:15 am	Tomorrow’s Cancer Care: A Government Policy Perspective Moderator: Jayson Slotnik, JD, MPH, Managing Partner, Health Policy Strategies Faculty: John Michael O’Brien, Advisor to the Secretary & Deputy Assistant Secretary for Health Policy, U.S. Department of Health & Human Services
9:15 am – 10:00 am	Tomorrow’s Cancer Care: An Insurance Payer’s Perspective Moderator: Michael Kolodziej, MD, VP and Chief Innovation Officer, ADVI Health LLC Faculty: Bryan Loy, MD, MBA, Medical Director, Oncology, Laboratory and Personalized Medicine, Humana John Fox, MD, MHA, Senior Medical Director, Priority Health Steve Peskin, MD, MBA, FACP, Executive Medical Director, Population Health, Horizon BCBS
10:00 am – 10:45 am	Tomorrow’s Cancer Care: A Center of Excellence Perspective Moderator: William McGivney, PhD, Managing Principal, McGivney Global Advisors Faculty: Raj Garg, MD, CEO, Cancer Treatment Centers of America Al Benson III, MD, Robert H. Lurie Comprehensive Cancer Center C. Lyn Fitzgerald, SVP, U.S. & Global Development, National Comprehensive Cancer Network
10:45 am – 11:15 am	Tomorrow’s Cancer Care: The Community-Based Care Perspective Moderator: Michael Kolodziej, MD, VP and Chief Innovation Officer, ADVI Health LLC Faculty: Barry Brooks, MD, Medical Director, US Oncology Debra Pratt, MD, MPH, MBA, VP, Texas Oncology Christian Downs, JD, MHA, CEO, Association of Community Cancer Centers Bruce Gould, MD
11:15 am – 12:00 pm	Networking Lunch \| Exhibit Hall Keynote Rowdy Gaines, Three-Time Olympic Gold Medalist and NBC Sports Commentator Distinguished Researchers Panel: Moderator: Neil Canavan, Author, The Cure Within Panelists: Jedd Wolchok, MD, Memorial Sloan Kettering Cancer Center Luis Diaz, MD, Memorial Sloan Kettering Cancer Center Axel Hoos, MD, President, Oncology, GlaxoSmithKline
12:00 pm – 12:45 pm	Keynote: Cancer Care into the Future Greg Simon, President, Biden Cancer Initiative
12:45 pm – 1:30 pm	Tomorrow’s Cancer Care: The Employer Perspective Moderator: Jonathan Fassberg, CEO, Solebury Trout Faculty: JPMorgan Chase & Co. PNC Bank Walmart or Amazon
1:30 pm – 2:15 pm	Tomorrow’s Cancer Care: A Pharma Perspective Moderator: William McGivney, PhD, Managing Principal, McGivney Global Advisors Faculty: Mikael Dolsten, MD, President, Worldwide Research & Development, Pfizer Axel Hoos, MD, SVP, Head, Oncology R&D, GlaxoSmithKline Joseph Leveque, Former CMO, ARMO Biosciences
Track 1: CLINICAL Track 2: ADVOCACY Track 3: TECHNOLOGY Track 4: SUPPLY CHAIN Track 5: BUSINESS Track 6: CONTRACTING Track 7: SPECIALTY PHARMACY Track 8: EMPLOYERS
2:15 pm – 3:15 pm	BREAKOUT 1: CLINICAL CAR-T Gene Therapy Immuno-Oncology Moderator: Morrie Ruffin, CEO, Adjuvant Partners Faculty: Alfred Slanetz, PhD, CEO, Genius Biotechnology Novartis Celgene BREAKOUT 2: TECHNOLOGY Artificial Intelligence in Cancer Treatment Design Moderator: Annatasiah Mhaka, PhD, Senior Advisor, Adjuvant Partners Faculty: George Daneker, MD, CMO, Cancer Treatment Centers of America BREAKOUT 3: SUPPLY CHAIN Oncology Supply Chain Moderator: Kevin Cast, Partner, Archbow Consulting Faculty: Rusty Massey, VP, Provider Relations, AmerisourceBergen Specialty Group, US Bioservices Patrick Schmidt, CEO, FFF Enterprises Lisa Harrison, Senior Director, Pharmacy and Clinical Services, ION Solutions BREAKOUT 4: ADVOCACY Tomorrow’s Cancer Care: The Patient Voice and Advocate Perspective Moderator: Robert Goldberg, PhD, VP, Center for Medicine in the Public Interest Faculty: Daniel Klein, President & CEO, Patient Access Network Foundation Clorinda Walley, CEO, Chronic Disease Fund Patricia Goldsmith, CEO, CancerCare Linda House, BSN, MSN, President, Cancer Support Community
3:15 pm – 4:15 pm	BREAKOUT 5: SUPPLY CHAIN CAR-T Pipeline and Market Access Moderator: Morrie Ruffin, CEO, Adjuvant Partners Faculty: Amy DuRoss, Co-Founder & CEO, Vineti Joel Brill, MD, CMO, Predictive Health, LLC BREAKOUT 6: TECHNOLOGY Big Data: “The New Oil” Moderator: Michael Kolodziej, MD, VP and Chief Innovation Officer, ADVI Health LLC Faculty: Brad Hirsch, MD, CEO, SignalPath Marcus Neubauer, MD, VP & Medical Director, Value-Based Reimbursement, McKesson Specialty Health IntrinsiQ AmerisourceBergen BREAKOUT 7: CONTRACTING Update on the CMS Oncology Care Model and Other Oncology Alternative Payment Models Moderator: Pamela Pelizzari, MPH, Healthcare Consultant, Milliman Faculty: Anand Shah, MD, CMO, Center for Medicare & Medicaid Innovation, Centers for Medicare & Medicaid Services Michael Ruiz de Somocurcio, VP, Payer & Provider Collaboration, Regional Cancer Care Associates BREAKOUT 8: BUSINESS The Burden of Cancer Care: Financial & Nonfinancial Costs Associated with Cancer Diagnosis & Treatment Moderator: Bruce Pyenson, FSA, MAAA, Principal and Consulting Actuary, Milliman Faculty: Christine Ferro, CHFP, Healthcare Analytics Consultant, Milliman Danielle Bubnis, Senior Director, Advocacy, The Leukemia & Lymphoma Society
4:15 pm – 5:15 pm	BREAKOUT 9: CLINICAL Genomics and Personalized Medicine Moderator: Louis Jacques, MD, ADVI Health LLC Faculty: Stan Skrzypczak, VP, Corporate Development & Reimbursement, Guardant Health Vince Miller, MD, CMO, Foundation Medicine Edward Abrahams, CEO, Personalized Medicine Coalition BREAKOUT 10: CONTRACTING Value-Based Oncology Drug Contracting Moderator: Jude Gallagher, PA, MBA, Former Director, Complex Clinical Care Strategy, Humana Faculty: A. Mark Fendrick, MD, Center for Value-Based Insurance Design, University of Michigan James Kenney Jr., RPh, MBA, VP, Harvard Pilgrim Health; President, Academy of Managed Care Pharmacy Brian Bourbeau, MBA, Associate Director, Business Metrics and Analysis, American Society of Clinical Oncology BREAKOUT 11: SUPPLY CHAIN Panel: Optimizing Patient Services Solutions in Cancer Care Moderator: Douglas Bock, Partner, Archbow Consulting Learnings: “HUB” types – What Is Really Needed and by Whom? Operational Optimization of Patient and Provider Support Services E-Services and the Evolution to Digitization Pharma Panel Members: Sumner Madden, Senior Director, Access360, AstraZeneca Mike Fitzgibbons, CEO, Claritas Rx BREAKOUT 12: EMPLOYERS Cancer Benefit Programs & Employers Moderator: Kevin Host, PharmD, President, COO, Pharmaceutical Strategies Group Faculty: Boeing Southwest Airlines
5:00 pm – 6:00 pm	Keynote: Cancer Drug Trend Report Moderator: Burt Zweigenhaft, Co-Chair, AVBCC Faculty: Doug Long, VP, Industry Relations, IQVIA
6:00 pm – 7:30 pm	Evening Network Reception

Wednesday, October 31

7:00 am – 8:00 am	Mini-Roundtables
7:00 am – 7:50 am	Breakfast Presentation \| Ballroom Oncology Drug Pipeline Overview, Next 3 Years Moderator: Burt Zweigenhaft, Co-Chair, AVBCC Faculty: Ray Tancredi, RPh, MBA, CSP, Divisional VP, Specialty Pharmacy Development & Brand Rx/Vaccine Purchasing, Walgreens Cheryl Allen, BS, PharmD, MBA, VP, Industry Relations, Diplomat Specialty Pharmacy
7:50 am – 8:00 am	Opening Remarks Michael Kolodziej, MD, VP and Chief Innovation Officer, ADVI Health LLC
8:00 am – 8:45 am	Keynote Clifford Hudis, MD, FACP, FASCO, CEO, American Society of Clinical Oncology
Track 1: CLINICAL Track 2: ADVOCACY Track 3: TECHNOLOGY Track 4: SUPPLY CHAIN Track 5: BUSINESS Track 6: CONTRACTING Track 7: SPECIALTY PHARMACY Track 8: EMPLOYERS
8:45 am – 9:45 pm	BREAKOUT 1: BUSINESS Strategies for Delivering on Pharmaceutical Value, a Focus on Quality Moderator: Darin Rubin, CEO, Managing Director, The Dedham Group LLC Faculty: Danielle Ziernicki, BS, RPh, PharmD, National Quality Forum, Steering Committee for Cancer Project, The Dedham Group LLC Ira Klein, MD, Johnson & Johnson Norris Turner, PharmD, PhD, Pharmacy Quality Alliance BREAKOUT 2: CLINICAL Biosimilars and Impact on Cancer Care Moderator: Robert Rifkin, MD, Medical Director, Biosimilars, US Oncology Network Faculty: Mark McClung, General Manager, Global Oncology, Amgen William Yoon, Head, Medical Acct Management & Strategic Alliances, Sandoz Robert Shelley, VP, Biosimilars Account Management, Pfizer BREAKOUT 3: BUSINESS The Pharma Food Chain—Driver of Inflation or Obstacle to Innovation? Moderator: Bruce Pyenson, FSA, MAAA, Principal and Consulting Actuary, Milliman Faculty: Richard Evans, Founder and General Manager, SSR LLC Brian DeBusk, CEO & President, DeRoyal; Vice Chair, Lincoln Memorial University; Commissioner, MedPAC Anna Kaltenboeck, Program Director and Senior Health Economist, Center for Health Policy & Outcomes, Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center BREAKOUT 4: BUSINESS Standardized Measurements and Process for Navigating Cancer Care Faculty: Tricia Strusowski, MS, RN, Manager, Oncology Solutions; Chair, AONN+ Evidence into Practice Metrics Subcommittee Danelle Johnston, MSN, RN, ONN-CG, OCN, Chief Nursing Officer, Senior Director of Strategic Planning & Initiatives, The Lynx Group
9:45 am – 10:45 am	Cancer Care Perspectives from Capitol Hill and in Emerging Public Policy Moderator: Marc Samuels, JD, MPH, Managing Partner, ADVI Health LLC Faculty: Kavita Patel, Fellow, Brookings Institution Liz Fowler, VP, Global Health Policy, Johnson & Johnson
10:45 am – 11:30 am	From K Street to Wall Street: A Look at Cancer Policy Influence on Markets Moderator: Ipsita Smolinski, CEO, Capitol Street Faculty: JPMorgan Chase & Co. PNC Bank Oncology Nurse & Nurse Navigators: Best Kept Secret in Value-Based Care Faculty: Brenda Nevidjon, RN, MSN, FAAN, CEO, Oncology Nursing Society Danelle Johnston, MSN, RN, ONN-CG, OCN, Chief Nursing Officer, Senior Director of Strategic Planning & Initiatives, The Lynx Group
11:30 am – 12:30 pm	Understanding Value Equations: Real-World Applications and Implications Moderator: William McGivney, PhD, Managing Principal, McGivney Global Advisors Faculty: Richard Schilsky, MD, FACP, FASCO, FSCT, SVP & CMO, American Society of Clinical Oncology Peter Bach, MD, Director, Center for Health Policy & Outcomes, Memorial Sloan Kettering Cancer Center
12:30 pm – 1:30 pm	Lunch
12:30 pm – 1:15 pm	Clinical Decision Support in the Midst of Rapid Scientific Innovation Moderator: Michael Kolodziej, MD, VP and Chief Innovation Officer, ADVI Health LLC Faculty: Robert J. Green, MD, SVP, Clinical Oncology, Flatiron Health Anand Shah, MD, MPH, CMO, Center for Medicare & Medicaid Innovation, Centers for Medicare & Medicaid Services Charles Saunders, CEO, Integra Connect Patient Panel Moderator: Peter Saltonstall, President & CEO, NORD
1:15 pm – 2:15 pm	PANEL DISCUSSION Pharmacy Benefit Managers & Their Role in Cancer Care Initiatives Moderator: Kevin Cast, Partner, Archbow Consulting Faculty: Everett Neville, RPh, EVP, Strategy, Supply Chain & Specialty, Express Scripts Surya Singh, MD, Corporate VP, Head, Medical Benefit Management, CVS Caremark Optum
2:15 pm – 3:15 pm	BREAKOUT 5: TECHNOLOGY Blockchain and Use Cases in Cancer Healthcare Moderator: John Bass, Founder, CEO, Hashed Health BREAKOUT 6: SPECIALTY PHARMACY Role of the Specialty Pharmacy in Cancer Care Moderator: Mike Ellis, RPh, CEO, Maxor National Pharmacy Services Company Faculty: Ray Bailey, Director of Pharmacy, Florida Cancer Specialists Matt Farber, MS, Senior Director, Walgreens Michael Reff, PharmD, President, National Community Oncology Dispensing Association Brian Seiz, PharmD, President, Accredo Specialty Pharmacy BREAKOUT 7: EMPLOYERS Employers and Business Health Coalitions Moderator: Randy Vogenberg, PhD, RPh, Partner, National Institute of Collaborative Healthcare Faculty: David Hom, Chief Evangelist, Scio Health Analytics BREAKOUT 8: TECHNOLOGY TITLE Moderator: Jennifer Hinkel, Partner, McGivney Global Advisors Faculty: Verily Life Sciences Center for Medical Technology Policy AmerisourceBergen
3:15 pm – 4:15 pm	BREAKOUT 9: BUSINESS TOPIC: Moderator: Faculty: Charles Stevens, MBA, JD, VP & Global Lead, Commercialization & Healthcare Communications, ICON plc BREAKOUT 10: EMPLOYERS Employers and Managing the Economic Reality of Cancer Spending Moderator: Randy Vogenberg, PhD, RPh, Partner, National Institute of Collaborative Healthcare BREAKOUT 11: TECHNOLOGY Value of Digital Medicine & Role in Cancer Care Moderator: Jayson Slotnik, JD, MPH, Managing Partner, Health Policy Strategies Faculty: Josh Stein, Co-Founder, CEO, AdhereTech BREAKOUT 12: BUSINESS Future Trends in the Cancer Care Ecosystem Moderator: Jennifer Hinkel, Partner, McGivney Global Advisors Faculty: Brenton Fargnoli, MD, Director, Product Marketing & Strategy/Medical Director, Value-Based Care, Flatiron Health Dan Mendelson, Founder & President, Avalere Health
4:15 pm – 4:30 pm	Closing Remarks

*Agenda is subject to change.